Processa Pharmaceuticals, Inc. Deferred State and Local Income Tax Expense (Benefit)
Processa Pharmaceuticals, Inc. (PCSA) reported Deferred State and Local Income Tax Expense (Benefit) of -$1.57 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-30.
Discontinued › Expense Statement › Income Tax
us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit · last filed 2023-03-30
- Processa Pharmaceuticals, Inc. deferred state and local income tax expense (benefit) for fiscal 2022 was -$1.57M.
- Processa Pharmaceuticals, Inc. deferred state and local income tax expense (benefit) for fiscal 2021 was -$624.84K.
- Processa Pharmaceuticals, Inc. deferred state and local income tax expense (benefit) for fiscal 2020 was -$907.50K.
- Processa Pharmaceuticals, Inc. deferred state and local income tax expense (benefit) for fiscal 2019 was -$234.03K.
| Period end | Deferred State and Local Income Tax Expense (Benefit) 12 month | Deferred State and Local Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|
| 2022-12-31 | -$1.57M 10-K · filed 2023-03-30 | |
| 2021-12-31 | -$624.84K 10-K · filed 2023-03-30 | |
| 2020-12-31 | -$907.50K 10-K · filed 2022-03-30 | -$907.50K 10-K · filed 2021-03-25 |
| 2019-12-31 | -$234.03K 10-K · filed 2021-03-25 | |
| 2018-12-31 | -$292.05K 10-K · filed 2020-03-06 | |
| 2017-12-31 | -$50.00K 10-K/A · filed 2019-04-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |